JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jentzen, W.
Right arrow Articles by Bockisch, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jentzen, W.
Right arrow Articles by Bockisch, A.
Journal of Nuclear Medicine Vol. 48 No. 1 108-114
© 2007 by Society of Nuclear Medicine


Basic Science Investigation

Segmentation of PET Volumes by Iterative Image Thresholding

Walter Jentzen, Lutz Freudenberg, Ernst G. Eising, Melanie Heinze, Wolfgang Brandau and Andreas Bockisch

Clinic for Nuclear Medicine, University of Duisburg-Essen, Essen, Germany

Correspondence: For correspondence or reprints contact: Walter Jentzen, PhD, Clinic for Nuclear Medicine, University of Duisburg-Essen, Hufelandstrasse 55, D-45122 Essen, Germany. E-mail: walter.jentzen{at}uni-duisburg-essen.de

The segmentation of metastatic volumes in PET is usually performed by thresholding methods. In a clinical application, the optimum threshold obtained from the adaptive thresholding method requires a priori estimation of the lesion volume from anatomic images such as CT. We describe an iterative thresholding method (ITM) used to estimate the PET volumes without anatomic a priori knowledge and its application to clinical images. Methods: The ITM is based on threshold-volume curves at varying source-to-background (S/B) ratio acquired from a body phantom. The spheres and background were filled either with 18F-FDG or Na124I (124I). These calibrated S/B-threshold-volume curves were used in estimating the volume by applying an iterative procedure. The ITM was validated with a PET phantom containing spheres and with 39 PET tumors that were discernable on CT by using whole-body 18F-FDG (15 patients) and 124I PET/CT (9 patients): The measured S/B ratios of the lesions were estimated from PET images, and their volumes were iteratively calculated using the calibrated S/B-threshold-volume curves. The resulting PET volumes were then compared with the known sphere inner volume and CT volumes of tumors that served as gold standards. Results: Phantom data analysis showed that the S/B-threshold-volume curves of 18F-FDG and 124I were similar. The average absolute deviation (expressed as a percentage of the expected volume) obtained in the PET validation phantom was 10% for volumes larger than 1.0 mL; sphere volumes of 0.5 mL showed a significantly larger deviation. For patients, the average absolute deviation for volumes between 0.8 and 7.5 mL was about 9% (31 lesions), whereas volumes larger than 7.5 mL showed an average volume mismatch of 15% (8 lesions). Conclusion: The ITM sufficiently estimated the clinical volumes in the range of 0.8–7.5 mL; volumes larger than 7.5 mL showed greater deviations that were still acceptable. These findings are associated with the limitation of the ITM. The ITM is especially useful for lesions that are only visible on PET. As a consequence, the lesion dosimetry is feasible with sufficient accuracy using PET images only.

Key Words: segmentation • PET • thresholding • PET/CT • radiotherapy • radioiodine therapy

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2007 48: 11a-12a. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
C. M. Costelloe, H. A. Macapinlac, J. E. Madewell, N. E. Fitzgerald, O. R. Mawlawi, E. M. Rohren, A. K. Raymond, V. O. Lewis, P. M. Anderson, R. L. Bassett Jr., et al.
18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma
J. Nucl. Med., March 1, 2009; 50(3): 340 - 347.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W. Jentzen, L. Freudenberg, E. G. Eising, W. Sonnenschein, J. Knust, and A. Bockisch
Optimized 124I PET Dosimetry Protocol for Radioiodine Therapy of Differentiated Thyroid Cancer
J. Nucl. Med., June 1, 2008; 49(6): 1017 - 1023.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.